Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
Clinical trial NCT05026177 · TERMINATED
Trial details
- NCT number
- NCT05026177
- Sponsor
- Cassava Sciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2024-12-30
- Enrollment
- 1125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.